Table of Contents
ISRN Gastroenterology
Volume 2012, Article ID 914824, 5 pages
http://dx.doi.org/10.5402/2012/914824
Research Article

Expression of COX2 and p53 in Rat Esophageal Cancer Induced by Reflux of Duodenal Contents

Department of Surgery, Kinki University, 377-2 Ohno-Higashi, Osaka Sayama, Osaka 589-8511, Japan

Received 2 September 2011; Accepted 3 October 2011

Academic Editor: A. Weimann

Copyright © 2012 Naoki Hashimoto. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Uys and P. D. Van Helden, “On the nature of genetic changes required for the development of esophageal cancer,” Molecular Carcinogenesis, vol. 36, no. 2, pp. 82–89, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. B. P. L. Wijnhoven, H. W. Tilanus, and W. N. M. Dinjens, “Molecular biology of Barrett's adenocarcinoma,” Annals of Surgery, vol. 233, no. 3, pp. 322–337, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Lagore, F. Paraf, D. Vidaud et al., “COX2 is expressed frequently and early in Barrett’s esophagus and associated adenocacinoma,” Histopathology, vol. 42, pp. 457–465, 2003. View at Google Scholar
  4. J. Lagergren, R. Bergström, A. Lindgren, and O. Nyrén, “Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma,” The New England Journal of Medicine, vol. 340, no. 11, pp. 825–831, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Kumagai, K. I. Mukaisho, H. Sugihara, K. Miwa, G. Yamamoto, and T. Hattori, “Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats,” Carcinogenesis, vol. 25, no. 5, pp. 723–727, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. K. Miwa, H. Sahara, M. Segawa et al., “Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats,” International Journal of Cancer, vol. 67, no. 2, pp. 269–274, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. K. H. Chen, K. I. Mukaisho, Z. Q. Ling, A. Shimomura, H. Sugihara, and T. Hattori, “Association between duodenal contents reflux and squamous cell carcinoma—establishment of an esophageal cancer cell line derived from the metastatic tumor in a rat reflux model,” Anticancer Research, vol. 27, no. 1 A, pp. 175–182, 2007. View at Google Scholar · View at Scopus
  8. E. M. Funkhouser and G. B. Sharp, “Aspirin and reduced risk of esophageal carcinoma,” Cancer, vol. 76, no. 7, pp. 1116–1119, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Kawamori, C. V. Rao, K. Seibert, and B. S. Reddy, “Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis,” Cancer Research, vol. 58, no. 3, pp. 409–412, 1998. View at Google Scholar · View at Scopus
  10. O. N. Tucker, A. J. Dannenberg, E. K. Yang et al., “Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer,” Cancer Research, vol. 59, no. 5, pp. 987–990, 1999. View at Google Scholar · View at Scopus
  11. K. C. Zimmermann, M. Sarbia, A. A. Weber, F. Borchard, H. E. Gabbert, and K. Schrör, “COX2 expression in human esophageal carcinoma,” Cancer Research, vol. 59, no. 1, pp. 198–204, 1999. View at Google Scholar · View at Scopus
  12. H. Wolff, K. Saukkonen, S. Anttila, A. Karjalainen, H. Vainio, and A. Ristimäki, “Expression of cyclooxygenase-2 in human lung carcinoma,” Cancer Research, vol. 58, no. 22, pp. 4997–5001, 1998. View at Google Scholar · View at Scopus
  13. F. A. Sinicrope and S. Gill, “Role of cyclooxygenase-2 in colorectal cancer,” Cancer and Metastasis Reviews, vol. 23, no. 1-2, pp. 63–75, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. B. P. Van Rees, K. Saukkonen, A. Ristimki et al., “Cyclooxygenase-2 expression during carcinogenesis in the human stomach,” Journal of Pathology, vol. 196, no. 2, pp. 171–179, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. C. A. Corcoran, Q. He, Y. Huang, and M. S. Sheikh, “Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis,” Oncogene, vol. 24, no. 9, pp. 1634–1640, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. O. Gallo, N. Schiavone, L. Papucci et al., “Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma,” American Journal of Pathology, vol. 163, no. 2, pp. 723–732, 2003. View at Google Scholar · View at Scopus
  17. J. A. Han, J. I. Kim, P. P. Ongusaha et al., “p53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis,” EMBO Journal, vol. 21, no. 21, pp. 5635–5644, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Benoit, E. De Moraes, N. A. Dar et al., “Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB,” Oncogene, vol. 25, no. 42, pp. 5708–5718, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. E. De Moraes, N. A. Dar, C. V. D. M. Gallo, and P. Hainaut, “Cross-talks between cyclooxygenase-2 and tumor suppressor protein p53: balancing life and death during inflammatory stress and carcinogenesis,” International Journal of Cancer, vol. 121, no. 5, pp. 929–937, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus